- Forums
- ASX - By Stock
- RCE
- [INTERVIEW] Recce Pharmaceuticals accelerates commercialisation with positive Phase II results
RCE
recce pharmaceuticals ltd
Add to My Watchlist
5.68%
!
41.5¢

[INTERVIEW] Recce Pharmaceuticals accelerates commercialisation with positive Phase II results
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
41.5¢ |
Change
-0.025(5.68%) |
Mkt cap ! $117.1M |
Open | High | Low | Value | Volume |
44.5¢ | 44.5¢ | 40.5¢ | $200.8K | 481.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 44453 | 42.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.5¢ | 914 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 45710 | 0.405 |
9 | 39268 | 0.400 |
3 | 15156 | 0.395 |
2 | 110000 | 0.390 |
1 | 25000 | 0.385 |
Price($) | Vol. | No. |
---|---|---|
0.410 | 486 | 1 |
0.415 | 50000 | 1 |
0.420 | 603 | 2 |
0.425 | 970 | 3 |
0.435 | 2301 | 1 |
Last trade - 13.35pm 11/09/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
EVR
EV RESOURCES LTD
Shane Menere, Non-Executive Chairman
Shane Menere
Non-Executive Chairman
SPONSORED BY The Market Online